You are here: Industry Insights > Bausch Health

News List

Bausch Health makes $200m bid for bankrupt Synergy Pharmaceuticals pharmaceutical-technology
December 17, 2018
Canada-based Bausch Health Companies (previously Valeant Pharmaceuticals) has entered a definitive agreement to acquire select assets of Synergy Pharmaceuticals for around $200m and certain assumed liabilities.....
Bausch Health buy bankrupt Synergy Pharmaceuticals for $200m pharmafile
December 14, 2018
Bankrupt drug developer Synergy Pharmaceuticals has announced that the company is to be acquired by Canadian speciality pharma firm Bausch Health for approximately $200 million in cash.
Cosmo wins FDA green light to challenge Bausch's Xifaxan fiercepharma
November 26, 2018
Bausch Health has yet to fully recover from its tainted past, and a new threat in the form of a rival to its top-seller Xifaxan could pile more pressure on the drugmaker.
Cosmo wins FDA green light to challenge Bausch's Xifaxan fiercepharma
November 22, 2018
Bausch Health has yet to fully recover from its tainted past, and a new threat in the form of a rival to its top-seller Xifaxan could pile more pressure on the drugmaker.
Meet the new Valeant: Drugmaker drops tainted name to become Bausch Health in July rebrand fiercepharma
May 09, 2018
Market watchers and Valeant investors have seen no shortage of changes at the company during its storied collapse. Now, the drugmaker is getting a new name to press ahead...

Previous page 1 2 Next page